DGX

Quest Diagnostics (DGX) RSI Live Chart

$250.85−0.41% 1DMC $27.60BNeutral

Quest Diagnostics (DGX) is trading around $250.85. Its daily RSI is 65.45, which is neutral, and its weekly RSI is 66.16 (neutral). The table below shows the live RSI on every timeframe.

Quest Diagnostics RSI by timeframe

TimeframeRSI (14)Signal
30m53.86Neutral
1h56.85Neutral
1d65.45Neutral
1w66.16Neutral
1mo70.16Overbought

Live, updates every few minutes. RSI period 14.

Quest Diagnostics at a glance

1 week
+3.23%
1 month
+7.55%
3 months
+7.31%
1 year
+42.74%
52-week high
$255.99
52-week low
$171.22
Market cap
$27.60B#333 in the S&P 500
In the S&P 500 since
2002

Quest Diagnostics (DGX) is an S&P 500 company in the Health Care sector, classified under Health Care Services and headquartered in Secaucus, New Jersey. Founded in 1967, it has been in the index since 2002. By market cap it is the 333rd largest company in the S&P 500 and the 45th largest of 60 in Health Care.

Over the past year DGX is up 42.7%, while the S&P 500 (SPY) is up 10.6%. It trades 2.0% below its 52-week high of $255.99 and 46.5% above its 52-week low of $171.22.

What the DGX RSI tells you

The Relative Strength Index (RSI) measures the speed and size of recent price moves on a scale from 0 to 100. It is one of the most widely used momentum indicators in stock trading.

A reading at or below 30 is considered oversold: selling may be overextended and a bounce more likely. A reading at or above 70 is overbought: buying may be stretched and a pullback more likely. Between 30 and 70 is neutral. Signals are strongest when several timeframes agree, which is why the table above shows Quest Diagnostics on all of them at once.

RSI is a guide, not a guarantee. A stock can stay oversold or overbought for a long time in a strong trend. Traders usually combine it with divergences, volume and structure, all of which you can check on the live chart.

More Health Care stocks

See all stocks